MedCity News

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

MedCity FemFwd: How Midwives Can Support the Maternal Health Crisis

In this episode, we’re joined by Amanda Shafton, practicing CNM and national director of midwifery at Ob Hospitalist Group. We discuss the benefits of physician/midwifery collaboration and how midwives can improve maternal health outcomes.

By Marissa Plescia

Health Tech

Little pink ceramic piggy bank pattern on the left side on yellow background. Concept of saving money, savings.

4 Notable Health Tech Funding Announcements in August

Health tech companies made several major funding announcements in August. Here is a list of some of the biggest funding rounds.

By Marissa Plescia

BioPharma, Pharma

First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic options. Originally developed by Protagonist Therapeutics, the engineered peptide gives Takeda a drug with blockbuster sales potential as the pharma company’s top overall product faces patent expirations.

By Frank Vinluan

Latest Video

Latest News

MedCity Influencers

AI Won’t Transform Health Systems, CEOs Will — 6 Principles to Drive the Transformation

If AI is not one of the CEO’s top two or three priorities, the organization will produce pilots and slide decks while better-mobilized peers pull ahead and the institution’s ability to fulfill its mission erodes

By Marc Harrison

Artificial Intelligence, Health Tech, Providers

Doctors and the Virtual Medical Revolution and Technological Advances Artificial Intelligence (AI) Deep Learning for Medical Research and Future Health Technology

Hospitals Are All In on AI, but Testing and Oversight Haven’t Caught Up

A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the infrastructure to properly test and validate them before they become embedded in patient care.

By Katie Adams

BioPharma, Pharma

SK Bio Broadens U.S. Prospects, Licensing Late-Stage Epilepsy Drug From Biohaven

Biohaven is outlicensing to SK Biopharmaceuticals global rights to opakalim, a Kv7-targeting small molecule in pivotal clinical testing for epilepsy. Biohaven gets non-dilutive financing for its pipeline while SK Bio gains another asset to potentially commercialize in the U.S.

By Frank Vinluan

MedCity Influencers

The Missing Piece in Lowering the Cost of Care: Predictability

When the healthcare system defaults to uncertainty, people delay care because it feels safer for their wallets. In some cases, people wait too long, leaving an ER visit as the path of least resistance.

By Morgan Kendrick

Health Tech, Hospitals, Providers

Epic MyChart Phishing Scam Hits Health Systems: What Providers Should Do

More than a dozen health systems are warning patients of a phishing campaign impersonating Epic's MyChart portal with fake Medicare rewards and faux login pages. Experts say the scam exposes a deeper problem: patients can't be expected to spot increasingly polished fakes, so the responsibility falls on providers to communicate in ways that build trust.

By Katie Adams

BioPharma, Pharma

FDA Nod for Inflammation Drug Notches Wins for Rare Disease Patients, Roivant’s Biz Strategy

Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory disorder dermatomyositis. Licensed from Pfizer, this once-daily pill designed to block JAK1 and TYK2 proteins is also in clinical development for three additional rare immunological disorders, each with blockbuster potential.

By Frank Vinluan

MedCity Influencers

The Silent Epidemic: Why Diabetic Foot Ulcers Have Been Overlooked for Three Decades

Chronic wounds demand clinicians willing to act outside of their defined role, not because the system incentivizes it, but because without it, the wound will not heal.

By Ned Swanson

Where Will AI Deployment Benefit Payers the Most?

We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.

By MedCity News

MedCity Influencers

A robot hand and a doctor's hand with a medical technology icon. A concept for human and AI collaboration in healthcare, robotic-assisted surgery, and the future of medicine.

Reading the Body’s Signals: AI’s Ultimate Healthcare Opportunity

We are on the cusp of an age of anticipatory medicine, an explosion in our ability to read the body's signals and catch the killers before they do their damage.

By Murray Brozinsky

BioPharma, Pharma

AstraZeneca, Amgen Drug Moves Closer to Competing With Dupixent in a New Indication

AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder whose only approved biologic therapy is Sanofi’s Dupixent. An approval for Tezspire in EoE would be its third indication, bolstering sales of the blockbuster product.

By Frank Vinluan

Health Tech, Providers

Female doctor and nurse conferring at reception desk in doctor's office

Datavant’s New Platform Could Cut Record Retrieval Time from Days to Hours

Datavant launched a new provider exchange platform, which replaces fax-based record requests with a digital workflow. It aims to give care teams real-time visibility into request status while easing the administrative burden on clinical staff.

By Katie Adams

MedCity Influencers

Precision Medicine Transformed Oncology —It’s Time to Do the Same for Sepsis

It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable.

By Bobby Reddy, Jr. and Dr. Nathan Shapiro

Events, Pharma

What Do the Latest Iteration of Consumer Drug Platforms Offer?

Consumer drug platforms and how they fit into the rise of the consumer in healthcare will be part of the conversation at INVEST Digital Health, scheduled for October 29 in Dallas. Register today!

By Stephanie Baum

Health Tech

Onos Health Raises $17M to Expand AI-Powered Behavioral Health Platform

Onos Health's Series A funding round was led by Costanoa, with support from Flare Capital Partners and CVS Health Ventures.

By Marissa Plescia

Devices & Diagnostics, Health Tech

Hackers work secretly in secret rooms. Mysterious colored lights Breaking into personal security and various agencies in the world . Wanted Hacker using computer for hacking in the cyber data center .

Cyberattack Disrupts Boston Scientific’s Operations: 7 Things to Know

Boston Scientific disclosed a cyberattack disrupting its global IT systems and order shipping capabilities, with the company unable to provide a timeline for when normal operations will resume. The disclosure adds the medical device giant to a growing list of medtech companies — including Stryker, Medtronic and Abbott — hit by major cyberattacks this year.

By Katie Adams

BioPharma, Pharma

Revolution Medicines Receives Landmark FDA Drug Approval in Pancreatic Cancer

FDA approval of Revolution Medicines’ daraxonrasib, brand name Rasonque, makes the molecule the first RAS inhibitor approved for treating pancreatic adenocarcinoma, the most common type of pancreatic cancer. The speedy regulatory nod specifically covers advanced cases of this type of cancer, which has had limited treatment options.

By Frank Vinluan